Neuren Pharmaceuticals Ltd (NEU) — Free Cash Flow Generation Index
Neuren Pharmaceuticals Ltd (NEU) has a Free Cash Flow Generation Index of 1.00x as of June 2025. Free cash flow of AU$128.30 Million represents 1% of operating cash flow (AU$128.31 Million). Explore NEU capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Neuren Pharmaceuticals Ltd Free Cash Flow Generation Index (2018–2023)
Historical FCF Generation Index trend for Neuren Pharmaceuticals Ltd across 3 annual periods. For the full cash flow conversion analysis, see Neuren Pharmaceuticals Ltd (NEU) cash conversion ratio.
Annual Free Cash Flow Generation for Neuren Pharmaceuticals Ltd (2018–2023)
Year-by-year Free Cash Flow Generation Index for Neuren Pharmaceuticals Ltd. Check NEU cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (AUD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | 1.00x | AU$184.88 Million | AU$184.93 Million | AU$40.00K | ▲ +0.5% |
| 2022 | 0.99x | AU$3.58 Million | AU$3.60 Million | AU$19.00K | ▼ -0.5% |
| 2018 | 1.00x | AU$6.41 Million | AU$6.41 Million | AU$12.00K | — |